Multiplex biomarker panels could also facilitate patient stratification, for instance, through the implementation of specific plasma tau species [178], and allow for individualized treatment approaches [179], which are essential for personalized medicine strategies in neurodegenerative diseases. This evidence concerns the gene MAPT and neurodegenerative disease.